All Companies
Ticker KALV
This stock is no longer actively trading
You reached the page — here's exactly what KALV is, and why it's out of scope for now.
What this ticker is
KALV
KalVista Pharmaceuticals, Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $1.4B
KalVista Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical firm dedicated to the discovery, development, and commercialization of small molecule protease inhibitors. These inhibitors aim to address diseases with significant unmet medical needs. The company's core therapeutic strategy centers on its pipeline of small molecule plasma kallikrei…
Why we can't analyze it yet
This ticker is delisted or inactive, so its financial data is frozen or incomplete and we don't produce a live analysis for it — the figures would be stale. Here's what the ticker is and why it's out of scope.
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
delisted